Abstract:Cognitive deterioration and memory decline associated with the progression of Alzheimer’s disease (AD) primarily results from synaptic failure. However, current understanding of the upstream regulatory mechanisms controlling synaptic plasticity remains limited. Salt-inducible kinase 3 (SIK3) is central to the signal pathway and is involved in neuronal regulation of sleep duration in mice. We speculated that the SIK3 cascade signaling pathway might contribute to the pathogenesis of AD. Thus, the present study employed AD transgenic mouse models, Morris Water Maze, virus-mediated gene transfer, electrophysiology, co-immunoprecipitation, western blotting, quantitative polymerase chain reaction, immunofluorescence, ChIP-qPCR, Golgi-Cox staining and dendritic spine analysis to investigate this connection. Our results revealed that SIK3 mRNA/protein expression was significantly reduced in middle-aged AD transgenic mouse models and AD patients. Conditional deletion of SIK3 gene in dorsal hippocampal neurons of 5×FAD mice further accelerated cognitive deterioration and impaired synaptic plasticity. In hippocampal neuronal cultures, SIK3 formed a complex with HDAC4, directly phosphorylated HDAC4 and regulated its nuclear cytoplasmic shuttle. Overexpression of SIK3 could facilitate the expression of synaptic plasticity-related genes by directly repressing mef2c or involving the recruitment of histone deacetylase to promoter regions of target genes through regulation of p-HDAC4, and vice versa. Moreover, up-regulation of SLP-S, the truncated fragment of SIK3, in dorsal hippocampal neurons, restored the synaptic plasticity and alleviates the cognitive impairment in 5×FAD mice. Collectively, these findings revealed a novel and important role of SIK3-HDAC4 regulation of synaptic plasticity and propose a new target for therapeutic approaches of cognitive deficits associated with AD.

HDAC4 Inhibits NMDA Receptor-Mediated Stimulation of Neurogranin Expression

HDAC4 Governs a Transcriptional Program Essential for Synaptic Plasticity and Memory

Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition

Conserved Higher-Order Chromatin Regulates Nmda Receptor Gene Expression and Cognition

Histone Deacetylase 2 Inhibition Attenuates Downregulation of Hippocampal Plasticity Gene Expression during Aging

Hdac2 Selectively Regulates Foxo3a-Mediated Gene Transcription During Oxidative Stress-Induced Neuronal Cell Death

Aberrant Expression of Histone Deacetylases 4 in Cognitive Disorders: Molecular Mechanisms and a Potential Target.

HDAC2 negatively regulates memory formation and synaptic plasticity

Increased Abundance of Nuclear HDAC4 Impairs Neuronal Development and Long-Term Memory

The histone deacetylase complex MiDAC regulates a neurodevelopmental gene expression program to control neurite outgrowth

Histone Deacetylase 2 Cell Autonomously Suppresses Excitatory and Enhances Inhibitory Synaptic Function in CA1 Pyramidal Neurons.

Dynamic regulation of NAT10-mediated mRNA acetylation at synapses by learning and memory in mouse hippocampus

Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease

Retraction Note: HDAC1-Mediated MicroRNA-124-5p Regulates NPY to Affect Learning and Memory Abilities in Rats with Depression

Targeting SIK3 to Modulate Hippocampal Synaptic Plasticity and Cognitive Function by Regulating the Transcription of HDAC4 in a Mouse Model of Alzheimer’s Disease

GSK-3β orchestrates the inhibitory innervation of adult-born dentate granule cells in vivo

Nicotinamide adenine dinucleotide promotes synaptic plasticity gene expression through regulation N-methyl-D-aspartate receptor/Ca2+/Erk1/2 pathway

Nectin-3 modulates the structural plasticity of dentate granule cells and long-term memory

Intracellular trafficking of histone deacetylase 4 regulates long-term memory formation.

Targeting SIK3 to modulate hippocampal synaptic plasticity and cognitive function by regulating the transcription of HDAC4 in a mouse model of Alzheimer's disease

The NMDA receptor subunit GluN3A regulates synaptic activity-induced and myocyte enhancer factor 2C (MEF2C)-dependent transcription